How Big Is the Exosome Market | Value & Future Opportunity 2025

Code: MTA6703 Publication Date: Jul 2025

How Big Is the Exosome Market?

According to 6Wresearch internal database and industry insights, the exosome market was valued at USD 264 million in 2024 and is anticipated to surpass USD 1.3 billion by 2031, expanding at a CAGR of 25.4%.

This growth is driven by the increasing utilization of exosomes in diagnostics, drug delivery, and regenerative medicine.

Growth Factors of the Exosome Market

  • Increase investment in sophisticated cancer diagnostic and cancer biomarkers.
  • More exosome-based targeted drug delivery platform use.
  • Growth in personalized medicine and precision therapies.
  • Advancement of RNA sequencing and liquid biopsy technology.
  • Increased interest in stem cell-derived exosomes for skin therapy.
  • Academic and clinical investigation supporting development.

Exosome Market Trends

The exosome market is experiencing expanded R&D with respect to applying extracellular vesicles to detect developing disease in the early stages. Additional interest is developing in exosome kits designed for non-invasive diagnostics. Biopharmaceutical companies are further exploring the use of exosome carriers in their development process to enhance cellular drug absorption.

Emerging Developments in the Exosome Market

Exosome purification and isolation technology is being expanded to become scalable for clinical use. The collaboration between biopharma start-ups and research universities is driving further product validation for both oncology and neurology applications.

Leading Companies in the Exosome Market

  • Thermo Fisher Scientific
  • QIAGEN
  • Lonza Group AG
  • Evox Therapeutics
  • Bio-Techne Corporation
  • ExoCoBio
  • Aegle Therapeutics
How Big Is the Exosome Market : FAQ's
The exosome market is expected to surpass USD 1.3 billion by 2031, led by advances in diagnostics and therapeutic delivery.
The market is expanding steadily, fueled by rising interest in non-invasive diagnostics, targeted therapies, and precision medicine.
Oncology leads the market, with exosomes used in both liquid biopsy diagnostics and cancer-targeted drug development.
Leading companies include Evox Therapeutics, Exosome Diagnostics (Bio-Techne), Codiak BioSciences, System Biosciences, and Aegle Therapeutics, driving innovation in diagnostics and drug delivery.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All